Drug interactions are numerous and varied, but not always clinically significant. Here we consider those factors that determine whether or not a drug interaction becomes clinically important, and the drugs commonly implicated in interactions.
Stockley's Drug Interactions, Royal Pharmaceutical Society, London, UK
Correspondence to Karen Baxter, Stockley's Drug Interactions, Royal Pharmaceutical Society, 1 Lambeth High Street, London, SE1 7JN, UK
Editor: R E Ferner, MSc, MD, FRCP, Director of the West Midlands Centre for Adverse Drug Reaction Reporting and Consultant Physician at City Hospital, Birmingham, UK. Assistant Editor: Mr C Anton, MA, MEng. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield, Denmark: Professor J S Schou; England: Dr J K Aronson; Ireland: Professor J Feely; Netherlands: Professor C J van Boxtel, Dr B H Ch Stricker; New Zealand: Dr T Maling; Scotland: Dr D N Bateman; Wales: Professor P A Routledge.